Connect your AI

CareDx CDNA Remainder of Fiscal Year 2024

Remainder of Fiscal Year 2024 at other companies

Natera, Inc.NTRA

——

NeoGenomicsNEO

——

Bio-Rad LaboratoriesBIO

——

VeracyteVCYT

——

Guardant HealthGH

——

Agilent TechnologiesA

——

Other financials

Income statement

Revenue$117.7M+39.0%

Operating income$1.2M+109%

Net income$2.8M+127%

EPS (diluted)$0.05+126%

Balance sheet

Cash & equivalents$78.5M-12.1%

Total debt$24.5M-19.1%

Total equity$313.5M-17.3%

Total assets$411.1M-16.0%

Cash flow

Operating cash flow$4.3M+116%

CapEx$3.8M+134%

Free cash flow$514.0K+102%

Valuation

Market cap$1.4B+32.2%

Enterprise value$1.35B+34.6%

P/S3.4×+0.3×

Profitability

Gross margin65.5%—

Operating margin-3.9%-18.3pp

Net margin-2%-19.9pp

FCF margin-0%0.0pp

Returns & leverage

Return on equity-2.4%-21.9pp

Debt / equity0.1×0.0×

Current ratio3.4×-0.7×

Where this comes from

Reported directly by CareDx in its filing.

Tagged under the XBRL concept us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear.

The official record: CareDx’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about CareDx's remainder of fiscal year 2024.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is CareDx's remainder of fiscal year 2024?: CareDx (CDNA) reported remainder of fiscal year 2024 of $5.91M in Q1 2026.
How has CareDx's remainder of fiscal year 2024 changed year-over-year?: CareDx's remainder of fiscal year 2024 decreased by 0.4% year-over-year, from $5.93M to $5.91M.